policy

ACAP Research Prescription Drugs

Programmatic Assessment of Carve-In and Carve-Out Arrangements for Medicaid Prescription Drugs

, , , 

Lewin Group and ACAP. “Programmatic Assessment of Carve-In and Carve-Out Arrangements for Medicaid Prescription Drugs.” October 2007.

View the full article »

Related Articles

ACAP Research Marketplaces

Overlap Issuers: Possible Drivers of Premium Reductions: June 2020

June 25, 2020
Comment Letter Prescription Drugs

PQA Comment Letter: Medicare and Medicaid Programs Contract Year 2021 and 2022

April 15, 2020
Plan Resource Coronavirus

COVID-19 – Brief Advice from Plan Leaders

April 6, 2020
Comment Letter Continuous Eligibility

Stakeholder Letter in Response to RFI on Maternal Health

April 6, 2020
Comment Letter Coronavirus

Sign-On Letter to President Trump: Invoke Defense Production Act to Save Lives

April 3, 2020
Comment Letter Coronavirus

Sign-On Letter: Give Families & States COVID-19 Support Now

March 24, 2020